MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan
· Delayed Price · Currency is TWD 6.80
+0.40 (6.25%)
Apr 28, 2026, 1:59 PM CST
MARX Biotech Market Cap
MARX Biotech has a market cap or net worth of 3.46 billion as of April 28, 2026. Its market cap has decreased by -2.71% in one year.
Market Cap
3.46B
Enterprise Value
3.80B
Revenue
712.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.80
Market Cap Chart
Since February 5, 2024, MARX Biotech's market cap has decreased from 4.38B to 3.46B, a decrease of -21.15%. That is a compound annual growth rate of -10.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.46B | 41.70% |
| Dec 31, 2025 | 2.44B | -30.65% |
| Dec 31, 2024 | 3.52B | -19.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 230.12B |
| Caliway Biopharmaceuticals | 155.17B |
| Heron Neutron Medical | 60.80B |
| Lotus Pharmaceutical | 58.87B |
| Maxigen Biotech | 3.54B |
| Nang Kuang Pharmaceutical | 3.53B |
| Merdury Biopharmaceutical | 3.50B |
| Genovate Biotechnology | 3.35B |